A pilot trial of personalized neoantigen pulsed autologous dendritic cell vaccine as adjuvant treatment in hepatocellular carcinoma

被引：0
|
作者：
Wu, Qiuji
Li, Qiu
Yang, Li
Xu, Heng
机构：
[1] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14658
引用
收藏
页数：1
相关论文
共 50 条
  • [11] PGV-001: A PHASE 1 TRIAL OF A PERSONALIZED NEOANTIGEN PEPTIDE VACCINE FOR THE TREATMENT OF MALIGNANCIES IN THE ADJUVANT SETTING
    Marron, Thomas
    Kodysh, Julia
    Rubinsteyn, Alex
    Finnigan, John
    Blazquez, Ana
    Saxena, Mansi
    Meseck, Marcia
    O'Donnell, Timothy
    Delbeau, Daniela
    Galsky, Matthew
    Doroshow, Deborah
    Miles, Brett
    Misiukiewicz, Krysztof
    Irie, Hanna
    Tiersten, Amy
    Parekh, Samir
    Posner, Marshall
    Wolf, Andrea
    Mandeli, John
    Hammerbacher, Jeffrey
    Donovan, Michael
    Brody, Rachel
    Gnjatic, Sacha
    Schadt, Eric
    Friedlander, Philip
    Bhardwaj, Nina
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A177 - A177
  • [12] A phase I clinical trial of autologous tumor lysate pulsed human dendritic cell vaccine in patients with colorectal carcinoma
    Wan, Tao
    Fu, Qiang
    Chen, Guoyou
    Jiang, Yingming
    Wu, Yanfeng
    Cao, Xuetao
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 903 - 904
  • [13] Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion
    Cai, Zhixiong
    Su, Xiaoping
    Qiu, Liman
    Li, Zhenli
    Li, Xiaolou
    Dong, Xiuqing
    Wei, Fuqun
    Zhou, Yang
    Luo, Liuping
    Chen, Geng
    Chen, Hengkai
    Wang, Yingchao
    Zeng, Yongyi
    Liu, Xiaolong
    MOLECULAR CANCER, 2021, 20 (01)
  • [14] Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion
    Zhixiong Cai
    Xiaoping Su
    Liman Qiu
    Zhenli Li
    Xiaolou Li
    Xiuqing Dong
    Fuqun Wei
    Yang Zhou
    Liuping Luo
    Geng Chen
    Hengkai Chen
    Yingchao Wang
    Yongyi Zeng
    Xiaolong Liu
    Molecular Cancer, 20
  • [15] Treatment of non-resectable hepatocellular carcinoma with autologous tumor-pulsed dendritic cells
    Ladhams, A
    Schmidt, C
    Sing, G
    Butterworth, L
    Fielding, G
    Tesar, P
    Strong, R
    Leggett, B
    Powell, L
    Maddern, G
    Ellem, K
    Cooksley, G
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 (08) : 889 - 896
  • [16] A first-in-human study to evaluate a personalized neoantigen-based mRNA-loaded dendritic cell vaccine, in combination with ablation, in patients with hepatocellular carcinoma
    Liang, Ping
    Yu, Jie
    Wang, Luo
    Chen, Si-Tong
    Dong, Guoping
    Hou, Qi-Di
    Zhang, Jing
    Cheng, Zhigang
    Han, Zhi-Yu
    Liu, Fang-Yi
    Yu, Xiao-Ling
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [17] Personalized Immunity: Neoantigen-Based Vaccines Revolutionizing Hepatocellular Carcinoma Treatment
    Aggeletopoulou, Ioanna
    Pantzios, Spyridon
    Triantos, Christos
    CANCERS, 2025, 17 (03)
  • [18] Personalized neoantigen DNA vaccine GNOS-PV02 and pembrolizumab as second-line treatment for advanced hepatocellular carcinoma
    Yarchoan, Mark
    Gane, Edward J.
    Marron, Thomas U.
    Perales-Linares, Renzo
    Yan, Jian
    Cooch, Neil
    Shu, Daniel
    Fertig, Elana J.
    Kagohara, Luciane T.
    Bartha, Gabor
    Northcott, Josette
    Lyle, John
    Rochestie, Sarah
    Peters, Joann
    Connor, Jason
    Jaffee, Elizabeth
    Perales-Puchalt, Alfredo
    Weiner, David B.
    Csiki, Ildiko
    Sardesai, Niranjan Y.
    CANCER RESEARCH, 2024, 84 (06)
  • [19] Autologous tumor cell pulsed - Dendritic cells as tumor vaccine.
    Kojima, M
    Morisaki, T
    Katano, M
    Nakamura, M
    Tanaka, M
    Torisu, M
    FASEB JOURNAL, 1997, 11 (03): : 3155 - 3155
  • [20] Personalized DNA neoantigen vaccine in combination with plasmid IL-12 and pembrolizumab for the treatment of patients with advanced hepatocellular carcinoma.
    Yarchoan, Mark
    Gane, Edward
    Marron, Thomas Urban
    Rochestie, Sarah
    Cooch, Neil
    Peters, Joann
    Csiki, Ildiko
    Perales-Puchalt, Alfredo
    Sardesai, Niranjan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345